Abvc Biopharma (ABVC) Share-based Compensation (IS) (2017 - 2026)
Abvc Biopharma (ABVC) posted Share-based Compensation (IS) of $845,607 for Q3 2026, down 49.2% from $1.66 million a year earlier but up 66.8% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Share-based Compensation (IS) (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Share-based Compensation (IS) at Abvc Biopharma was $791,980, down 79.9% year-over-year; for FY2025, it was $1.73 million, down 13.4% from FY2024.
- Annual Share-based Compensation (IS) shows a five-year compound annual growth rate of -16.1% (FY2020 to FY2025).
- In prior years, Abvc Biopharma's Share-based Compensation (IS) was $2 million in FY2024 (+271.8%), $536,648 in FY2023 (-92.4%), $7.04 million in FY2022 (+32.6%) and $5.31 million in FY2021 (+28.0%).
- Quarterly Share-based Compensation (IS) has run from a low of -$666,955 in Q4 2025 to a high of $4.69 million in Q1 2022 over five years.
- On a year-over-year basis, Share-based Compensation (IS) increased in four of the last seven quarters, with growth averaging 141.7%.
- The strongest year-over-year quarter for Share-based Compensation (IS) in the past five years was Q3 2025, with growth of 637.1%; the weakest was Q1 2025, with a decline of 78.4%.
- According to Business Quant data, Share-based Compensation (IS) for the three prior quarters was $507,041 (Q2 2026), $106,287 (Q1 2026) and -$666,955 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 845,607.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 845,607.00 |
| Jun 30, 2026 | 507,041.00 |
| Mar 31, 2026 | 106,287.00 |
| Dec 31, 2025 | -666,955.00 |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 682,345.00 |
| Mar 31, 2025 | 48,773.00 |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 225,740.00 |
| Jun 30, 2024 | 225,740.00 |
| Mar 31, 2024 | 225,740.00 |
| Dec 31, 2023 | 536,648.00 |
| Sep 30, 2023 | 817,740.00 |
| Jun 30, 2023 | 225,740.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 225,740.00 |
| Jun 30, 2022 | 225,740.00 |
| Mar 31, 2022 | 4.69 Mn |
| Dec 31, 2021 | 4.38 Mn |
| Sep 30, 2021 | 225,740.00 |
API Access
Abvc Biopharma Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();